Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 1.000 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.551 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.546 | |
1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.527 | |
2w17 | I19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.527 | |
1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.524 | |
3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.520 | |
2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.518 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.513 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.512 | |
3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.511 | |
4fkv | 61K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.507 | |
3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.505 | |
3uli | 1N3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.505 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.505 | |
2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.502 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.502 | |
4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.500 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.499 | |
1v1k | 3FP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
3sqq | 99Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.495 | |
3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.491 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.489 | |
3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.488 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.488 | |
3qxp | X64 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.485 | |
3rmf | 20Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.485 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.485 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.484 | |
2vtq | LZA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.484 | |
4fkw | 62K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.484 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.484 | |
5cvf | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.483 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.482 | |
3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.482 | |
4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.482 | |
1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
3nup | 3NU | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.480 | |
1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
3lfs | A07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
2vto | LZ8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.478 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.478 | |
4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.478 | |
4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.478 | |
3qtu | X44 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
4bcn | T9N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
2b55 | D31 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
2uzd | C85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
2w06 | FRV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.476 | |
1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.475 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
2c6o | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
3o0g | 3O0 | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.474 | |
4ix6 | ADP | Uncharacterized protein | / | 0.474 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.473 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.472 | |
1y91 | CT9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.472 | |
4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.472 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.472 | |
1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.471 | |
1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.471 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.471 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.470 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.470 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.469 | |
5cu6 | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.469 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.468 | |
1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.467 | |
2xmy | CDK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.467 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.466 | |
2vtt | LZD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.465 | |
3kkv | B99 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.465 | |
3llt | ANP | Protein serine/threonine kinase-1 | / | 0.465 | |
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.465 | |
1hck | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.464 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.464 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.464 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.464 | |
4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
1oiq | HDU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
1p2a | 5BN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.463 | |
3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.463 | |
3nga | 3NG | Casein kinase II subunit alpha | 2.7.11.1 | 0.463 | |
3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.463 | |
1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.462 | |
1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.462 | |
3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.462 | |
3ezr | EZR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.462 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.461 | |
3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.461 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.461 | |
4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.461 | |
4wsq | KSA | AP2-associated protein kinase 1 | 2.7.11.1 | 0.461 | |
2r3j | SCJ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.460 | |
2vtp | LZ9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
2w1h | L0F | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.459 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.459 | |
3qqk | X02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
3wow | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.459 | |
1w8c | N69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2euf | LQQ | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.458 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.458 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.458 | |
3r9o | Z71 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
3rpv | 26Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.458 | |
4ogr | ADN | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.458 | |
2b52 | D42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.457 | |
3qtr | X36 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
3ral | 04Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.457 | |
4ix5 | ANP | Uncharacterized protein | / | 0.457 | |
2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2vn9 | GVD | Calcium/calmodulin-dependent protein kinase type II subunit delta | 2.7.11.17 | 0.456 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.456 | |
4qny | ANP | Mitogen activated protein kinase, putative | / | 0.456 | |
3at3 | ATK | Casein kinase II subunit alpha | 2.7.11.1 | 0.455 | |
4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
1m2p | HNA | Casein kinase II subunit alpha | 2.7.11.1 | 0.454 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.454 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.454 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.454 | |
3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.454 | |
3r7y | Z04 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.454 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.454 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.454 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.453 | |
3eb0 | DRK | Uncharacterized protein | / | 0.453 | |
3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.453 | |
3rk7 | 08Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.453 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.453 | |
5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.453 | |
2bhe | BRY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.452 | |
3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.452 | |
3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.452 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.452 | |
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.452 | |
4ji9 | 1M3 | Tyrosine-protein kinase JAK2 | / | 0.452 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.452 | |
1pye | PM1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.451 | |
3qx2 | X63 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
4eor | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.451 | |
4lyn | 1YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.450 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.450 | |
4eon | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
5csh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
1jst | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2a0c | CK9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.449 | |
3bhh | 5CP | Calcium/calmodulin-dependent protein kinase type II subunit beta | 2.7.11.17 | 0.449 | |
3r71 | X86 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2ds1 | 1CD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.448 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
4jr7 | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.448 | |
5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.448 | |
2r3l | SCW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
3t14 | FAD | Sulfide-quinone reductase | / | 0.447 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.447 | |
4oau | ADP | 2-5A-dependent ribonuclease | 3.1.26 | 0.447 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.446 | |
1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.446 | |
3qcy | 3Q3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.446 | |
4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.446 | |
4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
1gij | 2PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3pe2 | E1B | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
3r1s | X73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.445 | |
4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.445 | |
1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
1urw | I1P | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
2b9j | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.444 | |
2c6t | DT5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3axw | TID | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
3lq5 | SLQ | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.444 | |
3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3sw7 | 19K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.444 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
1o6y | ACP | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.443 | |
1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
1pxp | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3dog | NNN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.443 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.443 | |
2cci | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2duv | 371 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.442 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.442 | |
1h0w | 207 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1om1 | IQA | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
1pxo | CK7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1q8y | ADP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.441 | |
1q99 | ANP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.441 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.441 | |
4q5h | ANP | Protein kinase OspG | 2.7 | 0.441 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
1h1q | 2A6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
1ke7 | LS3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.440 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.440 | |
4acd | GR9 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.440 | |
4acm | 7YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.440 | |
4b7s | QLE | Cytochrome P450 monooxygenase PikC | / | 0.440 | |
4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.440 | |
4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.440 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 |